Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ5D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,213
Award facts
- Contract value 100% obligated
- $40,213.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $40,213.49 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as the comprehensive global pharmaceutical supply vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in supplying branded and generic medications, vaccines, medical devices, and specialized healthcare commodities to federal agencies. The company's DLA contract vehicle demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains to support military treatment facilities, veteran healthcare systems, and other federal medical institutions worldwide. This specific delivery order for RINVOQ ER represents a routine pharmaceutical supply transaction within the broader strategic partnership between AmerisourceBergen and the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FJJ5D?
SPE2DR26FJJ5D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FJJ5D worth?
The government has obligated $40,213 on SPE2DR26FJJ5D.
Is contract SPE2DR26FJJ5D an order under another contract?
Yes. SPE2DR26FJJ5D is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ5D competed?
The extent of competition for SPE2DR26FJJ5D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award